SIRT1 and type 2 diabetes mellitus: In contrast, the effects of SIRT1 activation in Type 1 diabetes, a disease that unlike type 2 diabetes is characterized by ß-cell loss and insulinopenia, has not been previously investigated outside of its potential role in autoimmunity8.